ENTERA BIO LTD. Cost of Revenue
ENTERA BIO LTD. (ENTX) reported Cost of Revenue of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-07
- ENTERA BIO LTD. cost of revenue for the quarter ending 2026-06-30 was $0.00.
- ENTERA BIO LTD. cost of revenue for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- ENTERA BIO LTD. cost of revenue for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- ENTERA BIO LTD. cost of revenue for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- ENTERA BIO LTD. cost of revenue for fiscal 2025 was $42.00K, a 75.58% decline from fiscal 2024.
- ENTERA BIO LTD. cost of revenue for fiscal 2024 was $172.00K.
- ENTERA BIO LTD. cost of revenue for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- ENTERA BIO LTD. cost of revenue for fiscal 2022 was $101.00K, a 72.92% decline from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-07 | $0.00 10-Q · filed 2026-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-08-07 | $0.00 derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-05-08 | $0.00 derived: sum of 3 quarters · filed 2026-05-08 | $0.00 derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $0.00 derived: sum of 2 quarters · filed 2026-03-27 | $0.00 derived: sum of 3 quarters · filed 2026-08-07 | $42.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-07 | $42.00K 10-Q · filed 2025-11-14 | $124.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-07 | $42.00K 10-Q · filed 2026-08-07 | $124.00K derived: sum of 3 quarters · filed 2026-08-07 | $166.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $42.00K 10-Q · filed 2026-05-08 | $124.00K derived: sum of 2 quarters · filed 2026-05-08 | $166.00K derived: sum of 3 quarters · filed 2026-05-08 | $214.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $124.00K derived: sum of 2 quarters · filed 2026-03-27 | $172.00K derived: sum of 3 quarters · filed 2026-03-27 | $172.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $42.00K 10-Q · filed 2025-11-14 | $90.00K derived: sum of 2 quarters · filed 2025-11-14 | $90.00K 10-Q · filed 2025-11-14 | $90.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $48.00K 10-Q · filed 2025-08-08 | $48.00K 10-Q · filed 2025-08-08 | $48.00K derived: sum of 3 quarters · filed 2025-08-08 | $48.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-09 | $0.00 derived: sum of 2 quarters · filed 2025-05-09 | $0.00 derived: sum of 3 quarters · filed 2025-05-09 | $0.00 derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $0.00 derived: sum of 2 quarters · filed 2025-03-28 | $0.00 derived: sum of 3 quarters · filed 2025-03-28 | $0.00 10-K · filed 2025-03-28 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | $8.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-09 | $0.00 10-Q · filed 2024-08-09 | $8.00K derived: sum of 3 quarters · filed 2024-08-09 | $14.00K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-05 | $8.00K derived: sum of 2 quarters · filed 2024-03-08 | $14.00K derived: sum of 3 quarters · filed 2024-03-08 | $47.00K derived: sum of 4 quarters · filed 2024-03-08 |
| 2022-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $14.00K derived: sum of 2 quarters · filed 2024-03-08 | $47.00K derived: sum of 3 quarters · filed 2024-03-08 | $101.00K 10-K · filed 2024-03-08 |
| 2022-09-30 | $6.00K 10-Q · filed 2023-11-14 | $39.00K derived: sum of 2 quarters · filed 2023-11-14 | $93.00K 10-Q · filed 2023-11-14 | $229.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $33.00K 10-Q · filed 2023-08-11 | $87.00K 10-Q · filed 2023-08-11 | $223.00K derived: sum of 3 quarters · filed 2023-08-11 | $288.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $54.00K 10-Q · filed 2023-05-05 | $190.00K derived: sum of 2 quarters · filed 2023-05-05 | $255.00K derived: sum of 3 quarters · filed 2023-05-05 | $354.00K derived: sum of 4 quarters · filed 2023-05-05 |
| 2021-12-31 | $136.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $201.00K derived: sum of 2 quarters · filed 2023-03-31 | $300.00K derived: sum of 3 quarters · filed 2023-03-31 | $373.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $65.00K 10-Q · filed 2022-11-10 | $164.00K derived: sum of 2 quarters · filed 2022-11-10 | $237.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $99.00K 10-Q · filed 2022-08-11 | $172.00K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $73.00K 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $300.00K 10-K · filed 2022-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |